Showing results (101-110 of 172) with videos related to

Sort By:
Pageof 18
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 26, 2017
Dynamic molecular analysis and clinical correlates of tumor evolution within a phase II trial of panitumumab-based therapy in metastatic colorectal cancerS Siena, A Sartore-Bianchi, R Garcia-Carbonero, et al.
Acta Oncologica (Stockholm, Sweden)|October 25, 2007
Colorectal cancer metastasis resectability after treatment with the combination of oxaliplatin, irinotecan and 5-fluorouracil. Final results of a phase II studyAlbert Abad, Bartomeu Massuti, Antonio Antón, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 11, 2011
Trastuzumab-related cardiotoxicity in the elderly: a role for cardiovascular risk factorsC Serrano, J Cortés, L De Mattos-Arruda, et al.
ESMO Open|June 27, 2021
Trifluridine/tipiracil versus placebo for third or later lines of treatment in metastatic gastric cancer: an exploratory subgroup analysis from the TAGS studyJ Tabernero, K Shitara, A Zaanan, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 25, 2016
PAN-EX: a pooled analysis of two trials of neoadjuvant chemotherapy followed by chemoradiotherapy in MRI-defined, locally advanced rectal cancerF Sclafani, G Brown, D Cunningham, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 21, 2004
A multicentre, randomised phase II study of weekly or 3-weekly docetaxel in patients with metastatic breast cancerJ Tabernero, M A Climent, A Lluch, et al.
ESMO Gastrointestinal Oncology|February 6, 2026
Analysis of fruquintinib in patients with metastatic colorectal cancer who were enrolled in Spain: results from the global FRESCO-2 studyR Garcia-Carbonero, E Elez, P García-Alfonso, et al.
ESMO Open|April 10, 2026
New prognostic and predictive scoring systems for colorectal cancer liver metastasesF Salvà, S Pérez Fernandez, C Dopazo, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 17, 2014
Abituzumab combined with cetuximab plus irinotecan versus cetuximab plus irinotecan alone for patients with KRAS wild-type metastatic colorectal cancer: the randomised phase I/II POSEIDON trialE Élez, I Kocáková, T Höhler, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 15, 2013
A randomized phase II study of PEP02 (MM-398), irinotecan or docetaxel as a second-line therapy in patients with locally advanced or metastatic gastric or gastro-oesophageal junction adenocarcinomaA C Roy, S R Park, D Cunningham, et al.
Pageof 18